Petco Health and Wellness Company (WOOF) Earnings Dates, Call Summary & Reports

1,165 Followers

Earnings Data

Report Date

Aug 20, 2026

Before Open (Confirmed)

Period Ending

2026 (Q2)

Consensus EPS Forecast

0.07

Last Year’s EPS

0.09

Same Quarter Last Year

Analyst Consensus

Hold

Based on 10 Analysts Ratings

Earnings Call Summary

Q1 2026

Earnings Call Date:Jun 03, 2026|

% Change Since:

Earnings Call Sentiment|Positive

The call balanced multiple operational and financial improvements against a few persistent structural and external risks. Highlights include a return to positive comps (+0.7%), expanded margins (gross margin +21 bps), adjusted EBITDA growth (+8.8% YoY to $97.3M), strong services momentum (microchips +71% YoY, vet productivity gains), improved liquidity and lower debt, inventory discipline, and a reaffirmed full‑year outlook. Lowlights center on a Q1 free cash flow outflow of $69M, continued store closures and the fact management has not yet reclaimed market share, plus remaining leverage and reliance on tariff/fuel assumptions. Overall, positives and momentum from the Phase III strategy significantly outweigh the modest near‑term headwinds and conservatism in guidance.

Company Guidance

Management reaffirmed full‑year 2026 guidance: net sales flat to up 1.5% year‑over‑year and adjusted EBITDA of $415–$430 million, with Q2 guidance implying ~0.3% net‑sales growth and adjusted EBITDA of $110–$112 million. Key assumptions include fuel at current levels for the rest of the year, only the tariff refund received in May included (no further refunds assumed) and current tariff policies remaining; unchanged line‑item assumptions are net interest ≈ $125M, depreciation & amortization ≈ $200M, capex ≈ $140M, net store closures 15–20 (weighted to the back half), and a full‑year spread between total sales and comp sales of about 50 basis points. Management noted Q1 context—net sales $1.5B (+0.2%), comp +0.7%, adjusted EBITDA $97.3M, Q1 capex $10M, free cash flow outflow $69M, ending cash $167M, total liquidity $654.4M and total debt $1.48B—while reiterating a goal to reduce leverage to ~2x.

Return to Positive Comparable Sales

Comparable sales returned to positive, +0.7% comp, with net sales up 0.2% to $1.5B in Q1, demonstrating early traction from the Phase III strategy (note: net sales vs comp spread partly driven by 16 net store closures in 2025 and 4 in Q1).

Profitability Expansion and EBITDA Growth

Gross profit $574.4M and gross margin expanded 21 bps to 38.4%; SG&A was $549.8M (36.7% of sales) leveraging 34 bps; operating profit $24.6M, up 50.5% YoY; adjusted EBITDA $97.3M, up $7.9M or 8.8% YoY.

Services as a Growth Engine

Differentiated services (vet hospitals, clinics, grooming, training) continued to deliver strong results: grooming remains a high‑quality annuity, vet productivity improving, 'doctor days' rising, new Vetco clinic packages launched, free microchips drove a 71% increase in pets microchipped YoY, and the company is optimizing ~25 underutilized hospitals this year ahead of resumed hospital expansion in 2027.

Consumables, Cat Category and Fresh/Frozen Momentum

Consumables improved sequentially with notable outperformance in the cat category; management invested to be a destination for cat products and is ramping cat newness in Q2 (furniture, beds, bowls, trees). Company added freezer capacity and reiterated leadership in fresh/frozen pet nutrition; flea & tick season was the strongest start in five years.

Omnichannel Improvements and Loyalty Relaunch

Digital friction reduced leading to improved digital traffic; BOPIS was up strongly YoY, driving store visits and cross‑sell opportunity. Pilot of new loyalty program (Petco Perks) showed positive results and will relaunch broadly later this quarter, focused on simplified, personalized offers.

Balance Sheet and Liquidity Improvements

Ending cash $167M (+~$33M YoY), total liquidity $654.4M, total debt reduced to $1.48B (down >$100M YoY) after opportunistic refinancing that extended maturities to 2031; management reaffirmed goal to reduce leverage to ~2x.

Inventory Discipline

Ending inventory declined 1.9% YoY (following a 5.2% decline last year) even with sales growth, reflecting tighter inventory control while selectively investing to support growth.

Reaffirmed Full‑Year Guidance

Management reaffirmed full‑year outlook: net sales flat to +1.5% and adjusted EBITDA $415M–$430M; Q2 sales expected ~+0.3% and adjusted EBITDA $110M–$112M, indicating confidence in execution despite a dynamic macro backdrop.

Petco Health and Wellness Company (WOOF) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

WOOF Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Aug 20, 2026	2026 (Q2)	0.07 / -	0.089	―	―	―
Jun 03, 2026	2026 (Q1)	0.01 / 0.04	0.009	311.11% (+0.03)
Mar 11, 2026	2025 (Q4)	0.02 / 0.06	0.016	262.50% (+0.04)
Nov 25, 2025	2025 (Q3)	0.02 / 0.04	-0.02	280.00% (+0.06)
Aug 28, 2025	2025 (Q2)	0.01 / 0.09	-0.02	545.00% (+0.11)
Jun 05, 2025	2025 (Q1)	-0.02 / <0.01	-0.04	122.50% (+0.05)
Mar 26, 2025	2024 (Q4)	<0.01 / 0.02	0.02	-20.00% (>-0.01)
Dec 05, 2024	2024 (Q3)	-0.04 / -0.02	-0.05	60.00% (+0.03)
Sep 10, 2024	2024 (Q2)	-0.02 / -0.02	0.06	-133.33% (-0.08)
May 22, 2024	2024 (Q1)	-0.06 / -0.04	0.06	-166.67% (-0.10)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

WOOF Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Jun 03, 2026	$3.05	―	―
Mar 11, 2026	$2.40	$3.23	+34.58%
Nov 25, 2025	$2.97	$3.40	+14.48%
Aug 28, 2025	$3.23	$3.99	+23.53%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.